The Value of Everything: Making and Taking in the Global Economy

by Mariana Mazzucato

because public institutions funded most of the key scientific discoveries behind health innovations,42 taxpayers are now paying twice: first for the research and second for the premium that pharmaceutical companies charge for their drugs.